Together, the data presented here demonstrates a role for heterocellular OSM–OSMR signalling in establishing a pro-tumourigenic environment in PDA and highlights OSM–OSMR signalling as a putative therapeutic target in PDA. The gene discussed is OSM; the disease is Patent ductus arteriosus.